https://www.takeda.com/newsroom/shire-news-releases/2017/a2vckc/
Shire plc Director and Senior Management Changes
Shire plc Director and Senior Management Changes
shire plcsenior managementdirectorchanges
https://www.takeda.com/newsroom/shire-news-releases/2018/mxzwx6/
Shire plc : Form 8 (DD) - Flemming Ornskov
Shire plc : Form 8 (DD) - Flemming Ornskov
shire plcform 8ddflemmingornskov
https://www.takeda.com/newsroom/statements/2018/statement-regarding-improved-proposal-for-shire/
Takeda Statement Regarding Improved Proposal for Shire plc
Takeda Statement Regarding Improved Proposal for Shire plc
takedastatementregardingimprovedproposal
https://www.takeda.com/newsroom/shire-news-releases/2014/form-8-dd---shire-plc/
FORM 8 (DD) - Shire Plc
FORM 8 (DD) - Shire Plc
form 8ddshireplc
https://www.biospace.com/b-shire-pharmaceuticals-group-plc-b-third-quarter-2004-results-date-notification-4th-november
Shire Pharmaceuticals Group PLC Third Quarter 2004 Results Date Notification - 4th November -...
shire pharmaceuticals groupthird quarter
https://www.takeda.com/newsroom/newsreleases/2018/takeda-notes-statement-by-shire-plc-regarding-revised-proposal-and-extension-of-pusu-deadline-to-may-8-2018/
Takeda notes statement by Shire plc regarding revised proposal and extension of PUSU deadline to...
Takeda notes statement by Shire plc regarding revised proposal and extension of PUSU deadline to May 8, 2018
https://www.biospace.com/shire-pharmaceuticals-group-plc-second-quarter-2007-results-date-notification-26-july-2007
Shire Pharmaceuticals Group plc Second Quarter 2007 Results Date Notification - 26 July 2007 -...
shire pharmaceuticals groupsecond quarter
https://www.takeda.com/newsroom/shire-news-releases/2014/cancellation-of-listing-and-admission-to-trading-of-shire-plc-convertible-bonds-due-2014/
Cancellation Of Listing And Admission To Trading Of Shire Plc Convertible Bonds Due 2014
Cancellation Of Listing And Admission To Trading Of Shire Plc Convertible Bonds Due 2014
admission to trading